Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors
Open Access
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 11 (4) , 385-391
- https://doi.org/10.1023/a:1008351221345
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cellsEuropean Journal Of Cancer, 1997
- Specific Association of Cyclin-like Uracil-DNA Glycosylase with the Proliferating Cell Nuclear AntigenExperimental Cell Research, 1996
- The role of thymidylate synthase as an RNA binding proteinBioEssays, 1996
- Folate-based thymidylate synthase inhibitors as anticancer drugsAnnals of Oncology, 1995
- E2F-1 and a Cyclin-like DNA Repair Enzyme, Uracil-DNA Glycosylase, Provide Evidence for an Autoregulatory Mechanism for TranscriptionPublished by Elsevier ,1995
- Properties and levels of deoxynucleoside kinases in normal and tumor cells; implications for chemotherapyAdvances in Enzyme Regulation, 1994
- Identification of an RNA binding site for human thymidylate synthase.Proceedings of the National Academy of Sciences, 1993
- p53, guardian of the genomeNature, 1992
- Characteristics of thymidylate synthase purified from a human colon adenocarcinomaArchives of Biochemistry and Biophysics, 1988
- A kinetic model of regulation of the deoxyribonucleoside triphosphate pool compositionPharmacology & Therapeutics, 1984